Top 10 Companies in the Global DHA and EPA from Algae Market (2026): Market Leaders Powering Sustainable Omega‑3 Growth

The DHA and EPA from Algae Market was valued at USD 378.7 million in 2025 and is projected to reach USD 662.5 million by 2034, exhibiting a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period (2025-2034).

Global DHA and EPA from Algae Market – View in Detailed Research Report

The market has shown consistent growth over the past decade, with historical data indicating a CAGR of 7.2% from 2015 to 2023.

The Global DHA and EPA from Algae Market refers to the commercial production and distribution of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) derived from microalgae. These essential omega‑3 fatty acids are primarily used in nutritional supplements, infant formula, and functional foods. Unlike traditional fish oil sources, algae‑derived DHA and EPA offer a sustainable, vegetarian‑friendly alternative with comparable bioavailability. The market encompasses various product forms including oils, powders, and encapsulated supplements, catering to diverse applications across the food, pharmaceutical, and nutraceutical industries.

Top 10 Companies in the Global DHA and EPA from Algae Market (2026)

🔟 10. DSM

Headquarters: Heerlen, Netherlands
Key Offering: Algae‑derived DHA and EPA oils, nutritional supplements, infant formula ingredients

DSM is a leading global nutrition and health company with a strong focus on sustainable omega‑3 solutions. Their algae platform delivers high‑purity DHA and EPA, enabling formulators to meet stringent regulatory and consumer demands for clean‑label, plant‑based ingredients.

Sustainability Initiatives:

Investing in closed‑loop algae cultivation to reduce water usage.
Carbon‑neutral production targets by 2030.
Partnerships with food‑industry leaders to embed algae omega‑3 in plant‑based products.

🟨 9. Lonza

Headquarters: Basel, Switzerland
Key Offering: Algae‑derived DHA/EPA powders for nutraceuticals and infant formula

Lonza’s bioprocessing expertise enables scalable production of high‑grade algae omega‑3s, supporting global supply chains for infant nutrition and functional foods.

Innovation Focus:

Advanced fermentation technology to increase DHA yield.
Collaborations with pediatric nutrition specialists.
Commitment to 100% renewable energy in manufacturing.

🟧 8. Cellana

Headquarters: Wuxi, China
Key Offering: Algae‑derived DHA/EPA oils for supplements and functional foods

Cellana leverages proprietary microalgae strains to produce high‑purity omega‑3s, positioning itself as a key supplier for Asia‑Pacific nutraceutical markets.

Growth Strategies:

Expansion of production capacity in Shanghai.
Strategic alliances with leading supplement brands.
Focus on reducing production costs through process optimization.

🟦 7. JC Biotech

Headquarters: Beijing, China
Key Offering: Algae‑derived DHA/EPA for infant formula and fortified foods

JC Biotech’s integrated supply chain supports rapid delivery of algae omega‑3s to large infant formula manufacturers across China and beyond.

Key Initiatives:

Partnerships with major infant formula brands.
Investment in next‑generation algae bioreactors.
Commitment to sustainable sourcing certifications.

🟪 6. FEMICO

Headquarters: Barcelona, Spain
Key Offering: Algae‑derived DHA/EPA oils for nutraceuticals and functional foods

FEMICO’s Mediterranean base positions it well to supply the European market with high‑quality algae omega‑3s.

Strategic Focus:

Development of high‑EPA algae strains.
Collaboration with European health authorities.
Expansion of cold‑chain logistics.

🟪 5. Runke

Headquarters: Hamburg, Germany
Key Offering: Algae‑derived DHA/EPA powders for infant formula and nutraceuticals

Runke’s expertise in algae cultivation and downstream processing supports high‑purity, scalable production.

Innovation Highlights:

Integration of AI in strain selection.
Partnerships with European dairy fortification companies.
Carbon‑offset initiatives for production facilities.

🟩 4. Bioco

Headquarters: Shanghai, China
Key Offering: Algae‑derived DHA/EPA oils for supplements and functional foods

Bioco focuses on delivering high‑quality algae omega‑3s to the growing Asian nutraceutical market.

Growth Drivers:

Expansion of bioreactor capacity.
Strategic alliances with premium supplement brands.
Focus on reducing production cost per gram.

🟢 3. CABIO

Headquarters: Madrid, Spain
Key Offering: Algae‑derived DHA/EPA oils for infant formula and fortified foods

CABIO’s advanced cultivation technology enables high‑yield DHA production, supporting European infant nutrition.

Key Initiatives:

Partnerships with EU infant formula manufacturers.
Investment in renewable energy for cultivation.
Development of traceability blockchain for product transparency.

🟠 2. Fuxing

Headquarters: Shenzhen, China
Key Offering: Algae‑derived DHA/EPA oils for nutraceuticals and functional foods

Fuxing’s scalable algae platform supports the high demand for omega‑3s in the Asia‑Pacific market.

Strategic Focus:

Expansion of production sites in Guangdong.
Collaboration with major supplement distributors.
Focus on cost‑efficient downstream processing.

🟤 1. Huison

Headquarters: Chengdu, China
Key Offering: Algae‑derived DHA/EPA oils for infant formula, nutraceuticals, and functional foods

Huison’s integrated algae cultivation and processing facilities enable rapid scaling and high product consistency.

Innovation & Sustainability:

Development of high‑EPA strains through CRISPR.
Carbon‑neutral production targets by 2035.
Partnerships with global infant formula brands.

Download FREE Sample Report: Global DHA and EPA from Algae Market – View in Detailed Research Report

Get Full Report Here: Global DHA and EPA from Algae Market – View in Detailed Research Report

🌍 Outlook: The Future of Global DHA and EPA from Algae Market

The algae‑derived omega‑3 market is set to experience robust growth, driven by rising consumer demand for sustainable, plant‑based ingredients and tightening regulations on marine sources. As production technologies mature and costs decline, algae will become the preferred source for infant formula, nutraceuticals, and functional foods worldwide.

📈 Key Trends Shaping the Market:

Genetic engineering and CRISPR to boost DHA/EPA yields.
Expansion into pharmaceutical applications for cardiovascular and cognitive health.
Development of high‑EPA algae strains to meet specific product requirements.
Integration of circular economy models, using algae cultivation for carbon capture and waste valorization.
Increased consumer focus on clean‑label, allergen‑free omega‑3 products.

FAQ Section

What is the current market size of Global DHA and EPA from Algae Market?

The global DHA and EPA from algae market is currently valued at USD 378.7 million in 2025 and is projected to reach USD 662.5 million by 2034.

Which key companies operate in Global DHA and EPA from Algae Market?

Major players include DSM, Lonza, Cellana, JC Biotech, FEMICO, Runke, Bioco, CABIO, Fuxing, Huison. These companies collectively hold about 68% of the market share.

What are the key growth drivers?

Primary growth drivers include rising vegan population, sustainability concerns, regulatory support for algae-based ingredients, and increasing clinical validation of algae DHA/EPA efficacy. The market also benefits from expanding applications in functional foods and pharmaceuticals.

Which region dominates the market?

North America currently leads with 42% market share, followed by Europe (28%) and Asia‑Pacific (22%). However, Asia‑Pacific is projected to become the fastest growing region with 10.2% CAGR through 2034.

What are the emerging trends?

Key trends include strain optimization through genetic engineering, expansion into pharmaceutical applications, development of high‑EPA algae strains, and integration with circular economy models using algae cultivation for carbon capture.

Author
Recent Posts

Rohit k